| Vol. 15.15 – 21 April, 2021 |
| |
|
|
| Investigators profiled the transcriptome of 43,261 cells derived from Rax+ hypothalamic neuroepithelium to map the developmental landscape of the mouse hypothalamus and trajectory of radial glial cells, intermediate progenitor cells, nascent neurons, and peptidergic neurons. [Cell Stem Cell] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists revealed that the TAM system was an essential mediator of microglial recognition and engulfment of amyloid plaques and that TAM-driven microglial phagocytosis did not inhibit, but rather promoted dense-core plaque development. [Nature Immunology] |
|
|
|
| The authors showed that δ-secretase selectively cleaved UNC5C and escalated its proapoptotic activity, facilitating neurodegeneration in Alzheimer’s disease. [Science Advances] |
|
|
|
| Researchers report that neural progenitor cells and astrocytes differentiated from late-onset Alzheimer’s disease patient-derived induced pluripotent stem cells exhibited multiple inter-related bioenergetic alterations. [Molecular Psychiatry] |
|
|
|
| Using multiple genetic approaches, scientists showed that selective deletion of the PERK in mouse midbrain dopaminergic neurons resulted in multiple cognitive and motor phenotypes. [Molecular Psychiatry] |
|
|
|
| Based on the enzyme-mimicking properties, the constructed 2D vanadium carbide MXene nanoenzyme (MXenzyme) not only possessed high biocompatibility but also exhibited robust in vitro cytoprotection against oxidative stress. [Nature Communications] |
|
|
|
| Researchers showed that the type 1 integral membrane protein neuropilin-1 was expressed not on oligodendrocyte precursor cells but on amoeboid and activated microglia in white but not gray matter in an age- and activity-dependent manner. [Nature Communications] |
|
|
|
| The authors performed single-cell transcriptomics to define embryonic hypothalamic microglia heterogeneity and identified four microglial subsets, including a subpopulation adjacent to neural stem cells that were responsive to gestational cold stress. [Developmental Cell] |
|
|
|
| Investigators describe a mechanism by which depolarized neurons elevated the somatic ATP/ADP ratio in Drosophila glutamatergic neurons. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Scientists investigated the role of forkhead box transcription factor 3a (FOXO3a) in regulating the sensitivity of glioma cells to temozolomide and its relationship with Bcl-2/adenovirus E1B 19-kDa-interacting protein 3 (BNIP3)-mediated mitophagy. [Acta Pharmacologica Sinica] |
|
|
|
| Investigators explored the specific functions of M2 phenotype microglia-derived extracellular vesicles in ischemic brain injury progression. [Laboratory Investigation] |
|
|
|
| Both tumor suppressive and oncogenic functions have been reported for dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A). Investigators performed a detailed investigation to delineate the role of DYRK1A in glioblastoma. [Cell Death Discovery] |
|
|
|
|
| The authors reiterate the merit of using the α-syn preformed fibril model as a tool to understand the physiological changes associated with Lewy bodies while highlighting the neuroprotective potential of harnessing endogenous brain-derived neurotrophic factor. [npj Parkinson’s Disease] |
|
|
|
| Scientists show how understanding differences in the stability of attractor network systems in different brain areas can help to provide a scientific basis for relating some mental disorders to the operation of the underlying brain systems. [Translational Psychiatry] |
|
|
|
|
| LEXEO Therapeutics announced that the FDA has granted Fast Track designation to LX1001, the company’s adeno-associated virus-mediated gene therapy program, for the potential treatment of apolipoprotein E4 associated Alzheimer’s disease. [LEXEO Therapeutics] |
|
|
|
| Retrotope announced that enrollment has been completed for its multicenter Phase II clinical trial evaluating RT001, the company’s lead development candidate, in patients with ALS or Lou Gehrig’s disease. [Retrotope] |
|
|
|
|
| May 25 – 27, 2021 Virtual |
|
|
|
|
|
| University of British Columbia – Vancouver, British Columbia, Canada |
|
|
|
| Max Planck Institute – Nijmegen, Netherlands |
|
|
|
| University of Copenhagen – Copenhagen, Denmark |
|
|
|
| Icahn School of Medicine at Mount Sinai – New York, New York, United States |
|
|
|
| Boston Childrens Hospital – Boston, Massachusetts, Unted States |
|
|
|
|